US Patent Issued to Pontificia Universidad Catolica de Chile on June 30 for "Use of BCG immunogenic formulation expressing a respiratory syncitial virus protein against hMPV" (Chilean Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,611, issued on June 30, was assigned to Pontificia Universidad Catolica de Chile (Santiago, Chile).

"Use of BCG immunogenic formulation expressing a respiratory syncitial virus protein against hMPV" was invented by Alexis Kalergis (Santiago, Chile), Susan Bueno (Santiago, Chile) and Pablo Gonzalez (Santiago, Chile).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the novel use of an immunogenic formulation containing the bacillus Calmette-Guerin (BCG) strain at a concentration between 10-10deg bacteria, expressing at least one protein or immunogenic fragment of respiratory syncytial virus (RSV, Human Orthopneumovirus), in a pha...